Skip to content

Allevyn Gentle Border Foam Dressing versus control dressing in patients with rotator cuff repair

Allevyn Gentle Border Foam Dressing versus control dressing in patients with rotator cuff repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084792
Enrollment
Unknown
Registered
2024-05-24
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff injury

Interventions

control group :using conventional adhesive dressing (Cosmopor E Steri1)
experimental group:using a trial dressing (Allevyn Gentle Border Foam Dressing)

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (I)Aged 18 ~ 80 years old; (II) initial rotator cuff repair; (III) rotator cuff repair with the same method (surgical methods, suture methods and suture materials are the same); (IV) good patient compliance and ability to complete follow-up regularly; (V) voluntary participation in the study, signed informed consent.

Exclusion criteria

Exclusion criteria: (I)combined with hypertension, diabetes, hypoproteinemia, malnutrition (BMI 28 kg/m2), rheumatoid disease, tumor, connective tissue disease, hemophilia, limb vascular disease, psoriasis, radiation injury, gangrene, genetic diseases, anemia, gout, and other diseases that may affect wound healing; (II) long-term use of immunosuppressive agents, glucocorticoids, biological agents, anticoagulants, antiplatelet drugs, and preoperative no standardized adjustment and withdrawal; (III) long-term smoking or drinking history; (IV) history of surgery or infection at the surgical site; (V) scar, skin lesion, rash at surgical site prior to surgery; (VI) Invasive procedures such as acupuncture, small needle knife, and drug injection at the surgical site recently (within 1 month); (?) patients with psoriasis, eczema or dermatitis and other skin diseases; (?) allergic to any dressing components.

Design outcomes

Primary

MeasureTime frame
the incidence rate of wound complications; the cost-effectiveness of wound care;

Secondary

MeasureTime frame
the wound healing rate; the wound healing time;dressing wear time; number of dressing changes;evaluation of dressing performance;

Countries

China

Contacts

Public ContactPeng-cheng Li

West China Hospital, Sichuan University

16699411@qq.com+86 189 8060 1911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026